Working… Menu
Trial record 1 of 1 for:    NCT02843035
Previous Study | Return to List | Next Study

Venglustat in Combination With Cerezyme in Adult and Pediatric Patients With Gaucher Disease Type 3 (LEAP2IT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02843035
Recruitment Status : Recruiting
First Posted : July 25, 2016
Last Update Posted : June 2, 2021
Information provided by (Responsible Party):
Sanofi ( Genzyme, a Sanofi Company )

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2023
Estimated Study Completion Date : January 2023